Literature DB >> 26621387

Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.

Daniel J van Wamelen1, Raymund Ac Roos1, Nasir A Aziz1.   

Abstract

Aside from the well-known motor, cognitive and psychiatric signs and symptoms, Huntington disease (HD) is also frequently complicated by circadian rhythm and sleep disturbances. Despite the observation that these disturbances often precede motor onset and have a high prevalence, no studies are available in HD patients which assess potential treatments. In this review, we will briefly outline the nature of circadian rhythm and sleep disturbances in HD and subsequently focus on potential treatments based on findings in other neurodegenerative diseases with similarities to HD, such as Parkinson and Alzheimer disease. The most promising treatment options to date for circadian rhythm and sleep disruption in HD include melatonin (agonists) and bright light therapy, although further corroboration in clinical trials is warranted.

Entities:  

Keywords:  Huntington disease; bright light therapy; circadian rhythm; histamine; melatonin; modafinil; sleep

Mesh:

Year:  2015        PMID: 26621387     DOI: 10.2217/nmt.15.45

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  5 in total

Review 1.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

Review 2.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

3.  Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home.

Authors:  Jamie L Adams; Karthik Dinesh; Mulin Xiong; Christopher G Tarolli; Saloni Sharma; Nirav Sheth; A J Aranyosi; William Zhu; Steven Goldenthal; Kevin M Biglan; E Ray Dorsey; Gaurav Sharma
Journal:  Digit Biomark       Date:  2017-08-17

4.  Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders.

Authors:  Karen E Anderson; Erik van Duijn; David Craufurd; Carolyn Drazinic; Mary Edmondson; Nathan Goodman; Daniel van Kammen; Clement Loy; Josef Priller; LaVonne Veatch Goodman
Journal:  J Huntingtons Dis       Date:  2018

5.  Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.

Authors:  Koliane Ouk; Juliet Aungier; Michelle Ware; A Jennifer Morton
Journal:  eNeuro       Date:  2019-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.